Cargando…

Chemical- and Drug-Induced Allergic, Inflammatory, and Autoimmune Diseases Via Haptenation

SIMPLE SUMMARY: Allergic, inflammatory, or autoimmune diseases are characterized by exaggerated immune responses to harmless proteins such as pollen, dust mites, and foods in the environment or self-proteins. The number of cases has increased over the last 50 years. This is considered to be related...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakamoto, Eri, Katahira, Yasuhiro, Mizoguchi, Izuru, Watanabe, Aruma, Furusaka, Yuma, Sekine, Ami, Yamagishi, Miu, Sonoda, Jukito, Miyakawa, Satomi, Inoue, Shinya, Hasegawa, Hideaki, Yo, Kazuyuki, Yamaji, Fumiya, Toyoda, Akemi, Yoshimoto, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855847/ https://www.ncbi.nlm.nih.gov/pubmed/36671815 http://dx.doi.org/10.3390/biology12010123

Ejemplares similares

A Promising Needle-Free Pyro-Drive Jet Injector for Augmentation of Immunity by Intradermal Injection as a Physical Adjuvant
por: Sonoda, Jukito, et al.
Publicado: (2023)

Protective effects of conditioned media of immortalized stem cells from human exfoliated deciduous teeth on pressure ulcer formation
por: Katahira, Yasuhiro, et al.
Publicado: (2023)

A Chaperone-Like Role for EBI3 in Collaboration With Calnexin Under Inflammatory Conditions
por: Watanabe, Aruma, et al.
Publicado: (2021)

Potent antitumor effects of the conditioned medium of bone marrow‐derived mesenchymal stem cells via IGFBP‐4
por: Furusaka, Yuma, et al.
Publicado: (2023)

Induction of potent antitumor immunity by intradermal DNA injection using a novel needle‐free pyro‐drive jet injector
por: Inoue, Shinya, et al.
Publicado: (2022)

IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development
por: Hasegawa, Hideaki, et al.
Publicado: (2021)

Author Correction: IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development
por: Hasegawa, Hideaki, et al.
Publicado: (2021)

Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family
por: Hasegawa, Hideaki, et al.
Publicado: (2016)

Prediction of Chemical Respiratory and Contact Sensitizers by OX40L Expression in Dendritic Cells Using a Novel 3D Coculture System
por: Mizoguchi, Izuru, et al.
Publicado: (2017)

CARRIER FUNCTION IN ANTI-HAPTEN ANTIBODY RESPONSES : IV. EXPERIMENTAL CONDITIONS FOR THE INDUCTION OF HAPTEN-SPECIFIC TOLERANCE OR FOR THE STIMULATION OF ANTI-HAPTEN ANAMNESTIC RESPONSES BY "NONIMMUNOGENIC" HAPTEN-POLYPEPTIDE CONJUGATES
por: Katz, David H., et al.
Publicado: (1971)

Gamma delta T cells recognize haptens and mount a hapten-specific response
por: Zeng, Xun, et al.
Publicado: (2014)

ELICITATION OF DELAYED ALLERGIC SKIN REACTIONS WITH HAPTENS: THE DEPENDENCE OF ELICITATION ON HAPTEN COMBINATION WITH PROTEIN
por: Eisen, Herman N., et al.
Publicado: (1952)

ON THE USE OF ADSORBENTS IN IMMUNIZATIONS WITH HAPTENS
por: Jacobs, John
Publicado: (1934)

DELAYED HYPERSENSITIVITY TO HAPTEN-PROTEIN CONJUGATES : II. ANTI-HAPTEN SPECIFICITY AND THE HETEROGENEITY OF THE DELAYED RESPONSE
por: Silverstein, Arthur M., et al.
Publicado: (1962)

DELAYED HYPERSENSITIVITY TO HAPTEN-PROTEIN CONJUGATES : I. THE EFFECT OF CARRIER PROTEIN AND SITE OF ATTACHMENT TO HAPTEN
por: Cell, P. G. H., et al.
Publicado: (1962)

Hapten-reactive inducer T cells. I. Definition of two classes of hapten- specific inducer cells
Publicado: (1983)

Suppressor cells in tolerance to contact sensitivity active against hapten-syngeneic and hapten-allogeneic determinants
Publicado: (1977)

Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27
por: Xu, Mingli, et al.
Publicado: (2010)

Regulatory functions of hapten-reactive helper and suppressor T lymphocytes. I. Detection and characterization of hapten-reactive suppressor T-cell activity in mice immunized with hapten-isologous protein conjugate
por: Yamamoto, H, et al.
Publicado: (1977)

HAPTEN-CARRIER RELATIONSHIPS OF ISOANTIGENS : A MODEL FOR IMMUNOLOGICAL MATURATION BASED ON THE CONVERSION OF HAPTENS TO CARRIERS BY ANTIBODY
por: McBride, Raymond A., et al.
Publicado: (1970)

PERSISTENCE OF HAPTEN-ANTIBODY COMPLEXES IN THE CIRCULATION OF IMMUNIZED ANIMALS AFTER A SINGLE INTRAVENOUS INJECTION OF HAPTEN
por: Schmidt, Donald H., et al.
Publicado: (1974)

Hapten-specific hemolytic plaque assays usually fail to detect most of the diversity in the anti-hapten response
Publicado: (1977)

Altered Hapten Ligands Antagonize Trinitrophenyl-specific Cytotoxic T Cells and Block Internalization of Hapten-specific Receptors
por: Preckel, Tobias, et al.
Publicado: (1997)

Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines
por: Torres, Oscar B., et al.
Publicado: (2014)

Structural Analysis of Anti-Hapten Antibodies to Identify Long-Range Structural Movements Induced by Hapten Binding
por: Al Qaraghuli, Mohammed M., et al.
Publicado: (2021)

ON THE RÔLE OF CARBOHYDRATE HAPTENS IN BACTERIAL ANAPHYLAXIS
por: Tomcsik, Joseph, et al.
Publicado: (1928)

Haptenation: Chemical Reactivity and Protein Binding
por: Chipinda, Itai, et al.
Publicado: (2011)

Contact urticaria syndrome caused by haptens
por: Gomułka, Krzysztof, et al.
Publicado: (2014)

THE BEHAVIOR OF HAPTEN-POLY-L-LYSINE CONJUGATES AS COMPLETE ANTIGENS IN GENETIC RESPONDER AND AS HAPTENS IN NONRESPONDER GUINEA PIGS
por: Green, Ira, et al.
Publicado: (1966)

T cells specific for hapten-modified self are precommitted for self major histocompatibility complex antigens before encounter with the hapten
Publicado: (1978)

Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely
por: Ohyashiki, Junko H, et al.
Publicado: (2014)

Potential clinical application of interleukin-27 as an antitumor agent
por: Yoshimoto, Takayuki, et al.
Publicado: (2015)

CELLULAR HETEROGENEITY IN THE PRODUCTION OF AN ANTI-HAPTEN ANTIBODY
por: Mäkelä, O.
Publicado: (1967)

Cosmetics for neonates and infants: haptens in products’ composition
por: Dumycz, Karolina, et al.
Publicado: (2019)

Alternative Hapten Design for Zearalenone Immunoreagent Generation
por: Abad-Fuentes, Antonio, et al.
Publicado: (2022)

QUANTITATIVE INVESTIGATIONS OF IDIOTYPIC ANTIBODIES : IV. INHIBITION BY SPECIFIC HAPTENS OF THE REACTION OF ANTI-HAPTEN ANTIBODY WITH ITS ANTI-IDIOTYPIC ANTIBODY
por: Brient, Bruce W., et al.
Publicado: (1970)

CARRIER FUNCTION IN ANTI-HAPTEN IMMUNE RESPONSES : I. ENHANCEMENT OF PRIMARY AND SECONDARY ANTI-HAPTEN ANTIBODY RESPONSES BY CARRIER PREIMMUNIZATION
por: Katz, David H., et al.
Publicado: (1970)

IL-27 Enhances the Expression of TRAIL and TLR3 in Human Melanomas and Inhibits Their Tumor Growth in Cooperation with a TLR3 Agonist Poly(I:C) Partly in a TRAIL-Dependent Manner
por: Chiba, Yukino, et al.
Publicado: (2013)

INDUCTION OF IMMUNITY AND TOLERANCE IN VITRO BY HAPTEN PROTEIN CONJUGATES : I. THE RELATIONSHIP BETWEEN THE DEGREE OF HAPTEN CONJUGATION AND THE IMMUNOGENICITY OF DINITROPHENYLATED POLYMERIZED FLAGELLIN
por: Feldmann, Marc
Publicado: (1972)

INDUCTION OF IMMUNITY AND TOLERANCE IN VITRO BY HAPTEN PROTEIN CONJUGATES : III. HAPTEN INHIBITION STUDIES OF ANTIGEN BINDING TO B CELLS IN IMMUNITY AND TOLERANCE
por: Feldmann, Marc
Publicado: (1972)

Cannot write session to /tmp/vufind_sessions/sess_p2i0a9jf7uj4jr8ld7t3rjoud9